Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Centers for Disease Control and Prevention staffers are voicing frustration over Health Secretary Robert F. Kennedy Jr.’s ...

The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million.

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain s GSK and Germany s CureVac $740 ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency ...